![April Dovholuk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
April Dovholuk formerly worked at Replimune Group, Inc., as Senior VP-Clinical Development Operations and Centessa Pharmaceuticals Plc, as Senior Vice President-Operations Development from 2023 to 2024.
Dr. Dovholuk received her undergraduate degree from Cornell University.
Tidigare kända positioner av April Dovholuk
| Företag | Position | Slut |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Verksamhetschef | 2024-11-01 |
| REPLIMUNE GROUP, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
April Dovholuks utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
1
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Centessa Pharmaceuticals Plc
 Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
